Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
ENGN holding history
enGene Therapeutics Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENGN overviewAll 13F holders of ENGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 600,000
- Value
- $1.04M
- % of portfolio
- 0.1%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 600,000 | $1.04M | 0.1% | −10,370−1.7% | Reduced | Holders |
| Q1 2026 | 610,370 | $4.16M | 0.2% | −33,000−5.1% | Reduced | Holders |
| Q4 2025 | 643,370 | $5.81M | 0.4% | +566,370+735.5% | Added | Holders |
| Q3 2025 | 77,000 | $525.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 77,000 | $280.3K | <0.1% | +77,000 | New | Holders |